At the 43rd VEITHsymposium, Dr. Ansel presented data from the randomized controlled trial studying the Zilver PTX drug-eluting stent (DES) vs percutaneous transluminal angioplasty and bare-metal stents. He shared new findings from subanalyses...
At the 43rd VEITHsymposium, Dr. Ansel presented data from the randomized controlled trial studying the Zilver PTX drug-eluting stent (DES) vs percutaneous transluminal angioplasty and bare-metal stents. He shared new findings from subanalyses...
Dr. Walker discusses an article from the December issue of Vascular Disease Management, in which Mengal et al present a case for which they utilized Wallgraft stents to treat a symptomatic arterial aneurysm involving the distal portion of the...
Dr. Walker discusses an article from the December issue of Vascular Disease Management, in which Mengal et al present a case for which they utilized Wallgraft stents to treat a symptomatic arterial aneurysm involving the distal portion of the...
Dr. Walker discusses the November 2016 article by Richards and Schneider that explores the factors involved in the discrepancy between patency and limb salvage rates in critical limb ischemia.
Dr. Walker discusses the November 2016 article by Richards and Schneider that explores the factors involved in the discrepancy between patency and limb salvage rates in critical limb ischemia.
Carotid stenting has been a source of debate in the United States cardiovascular community. This is not the case in many other countries, where carotid stenting is the most commonly utilized treatment of atherosclerotic carotid disease. New...
Carotid stenting has been a source of debate in the United States cardiovascular community. This is not the case in many other countries, where carotid stenting is the most commonly utilized treatment of atherosclerotic carotid disease. New...
Vascular Disease Management clinical editor Craig Walker, MD, introduces the September 2016 issue of VDM with a discussion of the article by Jos C. van den Berg, MD, on femoral and popliteal in-stent restenosis. Important points for...
Vascular Disease Management clinical editor Craig Walker, MD, introduces the September 2016 issue of VDM with a discussion of the article by Jos C. van den Berg, MD, on femoral and popliteal in-stent restenosis. Important points for...
The popliteal artery historically has been one of the most challenging arteries in which to perform endovascular treatment. Further study of endovascular therapy for popliteal artery injury could lead to appropriate utilization of...
The popliteal artery historically has been one of the most challenging arteries in which to perform endovascular treatment. Further study of endovascular therapy for popliteal artery injury could lead to appropriate utilization of...
Any therapy that can reduce pain for patients for whom revascularization is not possible is worth the attention of interventionalists. Compression therapy has the potential to improve mortality, increase amputation-free survival, and reduce...
Any therapy that can reduce pain for patients for whom revascularization is not possible is worth the attention of interventionalists. Compression therapy has the potential to improve mortality, increase amputation-free survival, and reduce...
There is a lack of standardization in today’s treatment of peripheral arterial disease. The article by Nicolas Shammas, MD, in the June issue of Vascular Disease Management proposes an algorithm for therapy. In this video, Dr. Walker...
There is a lack of standardization in today’s treatment of peripheral arterial disease. The article by Nicolas Shammas, MD, in the June issue of Vascular Disease Management proposes an algorithm for therapy. In this video, Dr. Walker...
Dheeraj K. Rajan, MD, FRCPC, FSIR, describes 12- and 24-month follow-up data from the Fluency Plus Endovascular Stent Graft for In-stent Restenosis (the RESCUE study).
Dheeraj K. Rajan, MD, FRCPC, FSIR, describes 12- and 24-month follow-up data from the Fluency Plus Endovascular Stent Graft for In-stent Restenosis (the RESCUE study).
Michael Temple, MD, a pediatric interventional radiologist at the Hospital for Sick Children in Toronto, Ontario, discusses results of a multi-institutional study of inferior vena cava filter use in children.
Michael Temple, MD, a pediatric interventional radiologist at the Hospital for Sick Children in Toronto, Ontario, discusses results of a multi-institutional study of inferior vena cava filter use in children.
